• 11 Hits
  • Search Condition : Filter (MeSH = Proto-Oncogene Proteins c-met / genetics*)
Species Resource Title
Human and Animal Cells Ba/F3-CL1(RCB4474) Intra-tumor and Inter-tumor Heterogeneity in MET Exon 14 Skipping Mutations and Co-mutations in Pulmonary Pleomorphic Carcinomas.
Human and Animal Cells A549(RCB0098) , LC-2/ad(RCB0440) Inhibition of ABCB1 Overcomes Cancer Stem Cell-like Properties and Acquired Resistance to MET Inhibitors in Non-Small Cell Lung Cancer.
Human and Animal Cells MRC-5(RCB0218) MET Copy Number Gain Is Associated with Gefitinib Resistance in Leptomeningeal Carcinomatosis of EGFR-mutant Lung Cancer.
Human and Animal Cells KP4(RCB1005) ABBV-399, a c-Met Antibody-Drug Conjugate that Targets Both MET-Amplified and c-Met-Overexpressing Tumors, Irrespective of MET Pathway Dependence.
Human and Animal Cells MKN45(RCB1001) Regulation of MET kinase inhibitor resistance by copy number of MET in gastric carcinoma cells.
Human and Animal Cells HSC-4(RCB1902) , SAS(RCB1974) , Ca9-22(RCB1976) Migration of oral squamous cell carcinoma cells are induced by HGF/c-Met signalling via lamellipodia and filopodia formation.
Human and Animal Cells JHOC-5(RCB1520) , JHOC-7(RCB1688) , JHOC-8(RCB1723) , JHOC-9(RCB2226) Met is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis.
Human and Animal Cells WEHI-3(RCB0035) , Ba/F3 Sensitivity and Resistance of MET Exon 14 Mutations in Lung Cancer to Eight MET Tyrosine Kinase Inhibitors In Vitro.
DNA material pENTR4-H1 (RDB04395) , CS-RfA-CG (RDB04390) , pCAG-HIVgp (RDB04394) , pCMV-VSV-G-RSV-Rev (RDB04393) Mathematical analysis of gefitinib resistance of lung adenocarcinoma caused by MET amplification.
Human and Animal Cells GSU(RCB2278) , Kato III(RCB2088) , KE-97(RCB1435) , MKN45(RCB1001) , NUGC-4(RCB1939) A novel inhibitor of c-Met and VEGF receptor tyrosine kinases with a broad spectrum of in vivo antitumor activities.
Human and Animal Cells MRC-5 Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway.